Presented as part of the Uniting the global community to face the challenge of addiction event, online on 16th May, 2022
- Psychiatric Co-Morbidity and Substance Use Associated with Medication Adherence Among People Living with HIV, Virology Clinic of University of Port Harcourt Teaching Hospital - Dr Aborlo Kennedy Nkporbu
Psychiatric Co-Morbidity and Substance Use Associated with Medication Adherence Among People Living with HIV, Virology Clinic of University of Port Harcourt Teaching Hospital - Dr Aborlo Kennedy Nkporbu
Background: HIV infection is an endemic communicable chronic disease, of enormous public health concern worldwide particularly, Sub-Saharan African. Substance use and associated psychiatric co-morbidity among the sufferers may affect medication adherence.
Aim: To determine the effect of psychiatric co-morbidity and substance use on medication adherence among people living with HIV at the University of Port Harcourt Teaching Hospital.
Methods:A cross-sectional study was conducted among 230 Subjects Living with HIV. Socio-demographic questionnaire was used. A structured questionnaire was used to assess use of psychoactive substances. Psychiatric co-morbidity was assessed using the GHQ-12 in conjunction with the DSM 5. The MARS was used to assess medication adherence. Data was analysed using the SPSS version 20.
Results:The prevalence of psychological co-morbidity among PLWHIV was 30.6%. Alcohol use disorders was the highest with 73 (31.7%), followed by cigarette smoking 38 (16.5%) while nicotine snuffing was the least with 1 (0.4%). Of the 43(18.7%) with poor medication adherence, 31(15.2%) had psychiatric co-morbidity, 26(11.3%) had substance use, 25(10.8%) had both psychiatric and substance use co-morbidity while 19(8.2%) had none (p=0.004).
Conclusion:Psychological co-morbidity and substance use are prevalent among PLWHIV, and may affect medication adherence.
Keywords: Psychological co-morbidity, Substance use, Medication adherence, PLWHIV.
- At the end of this presentation, participants should be able to appreciate the complex interplay of medical condition, mental disorder, substance use and drug adherence.
- At the end of this presentation, participants should be able to understand the pattern of psychiatric co-morbidity and drug use among PLWHIV.
- At the end of this presentation, participants should be able to embrace the need for appropriate preventive and treatment psychosocial measures for PLWHIV.
Other author names
- Dr. Ayodeji O
- Prof. P.C. Stanley